Modulating pharmacokinetics is a core strength of our drug design and development services. We utilize a full range of established modified release technologies, often in combination with solubility-enhancing technologies, to meet target product profiles. Our product development teams utilize specialized processing techniques and phase-appropriate equipment to ensure effective product development and manufacturing from concept, through clinical studies to commercialization.
Immediate release, delayed release and enteric protection, extended release, fixed dose combinations, dual and pulsatile release, and site specific targeting, including colonic delivery, are routinely utilized to meet our customers’ target product profiles and commercial objectives. These highly flexible technologies are formulated into either monolithic or multiparticulate drug product formats. Our product development teams work closely with you to define problem statements, and choose the best formulation approach.
*SCT = osmotic swellable-core technology
*LMP = lipid multiparticulate technology